OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
24
Results
Show all
Save search
Copy query
Show results for
Unknown
(24)
Publication Date
Release Date
2025
(5)
2021
(5)
2022
(4)
2024
(3)
2023
(3)
2015
(2)
2026
(1)
2016
(1)
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
Overall Survival and Long-Term Safety of Nivolumab (Anti-Programmed Death 1 Antibody, BMS-936558, ONO-4538) in Patients With Previously Treated Advanced Non-Small-Cell Lung Cancer.
Not available
S-EPMC4672027
|
biostudies-literature
Cite
A multicentre prospective registry of one thousand sepsis patients admitted in Indian ICUs: (SEPSIS INDIA) study.
Not available
S-EPMC11577944
|
biostudies-literature
Cite
Intensive Care in India: The Indian Intensive Care Case Mix and Practice Patterns Study.
Not available
S-EPMC4859158
|
biostudies-literature
Cite
Clinical utility of random anti-tumor necrosis factor drug-level testing and measurement of antidrug antibodies on the long-term treatment response in rheumatoid arthritis.
Not available
S-EPMC4843946
|
biostudies-literature
Cite
Association of Renin Angiotensin Aldosterone System Inhibitors and Outcomes of Hospitalized Patients With COVID-19.
Not available
S-EPMC9469914
|
biostudies-literature
Cite
SARS-CoV-2 infection increases risk of acute kidney injury in a bimodal age distribution.
Not available
S-EPMC8831033
|
biostudies-literature
Cite
Metabolic Syndrome and Acute Respiratory Distress Syndrome in Hospitalized Patients With COVID-19.
Not available
S-EPMC8696573
|
biostudies-literature
Cite
The Association of Baseline Plasma SARS-CoV-2 Nucleocapsid Antigen Level and Outcomes in Patients Hospitalized With COVID-19.
Not available
S-EPMC9447373
|
biostudies-literature
Cite
Early trajectories of virological and immunological biomarkers and clinical outcomes in patients admitted to hospital for COVID-19: an international, prospective cohort study.
Not available
S-EPMC11181148
|
biostudies-literature
Cite
Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023.
Not available
S-EPMC12535840
|
biostudies-literature
Cite
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets